Author: NewsCancer

Pancreatic cancer is one of the most difficult cancers to diagnose early, and it often does not respond well to standard treatments. Because of this, scientists are searching for new ways to stop the disease before it advances. Researchers already understand that nerves can help cancer spread, but what happens in the earliest phases of pancreatic cancer has remained uncertain. “One phenomenon that is known is called perineural invasion,” says Jeremy Nigri, a postdoc in Professor David Tuveson’s lab at Cold Spring Harbor Laboratory (CSHL). “This means cancer cells will migrate within the nerve and use the nerve as a…

Read More

Receiving an mRNA COVID-19 vaccine shortly before or at any point during pregnancy is not linked to autism or other developmental disorders in children, according to research presented at the Society for Maternal-Fetal Medicine (SMFM) 2026 Pregnancy Meeting. The findings provide new data on the long term health of children whose mothers were vaccinated around the time of pregnancy. In the United States, two types of COVID-19 vaccines are recommended: the messenger ribonucleic acid (mRNA) vaccine and a protein subunit vaccine. Both are considered safe during all stages of pregnancy and are recommended to help safeguard both maternal and infant…

Read More

The PRECEDE Consortium provides a standardized, large-scale infrastructure for the early detection of pancreatic cancer, addressing a clinical landscape where five-year survival rates have remained stagnant at 13%, according to Diane Simeone, MD. This 13% 5-year survival rate was noted in a study published by American Cancer Society, which also showed that across all combined cancer types, the 5-year survival rate was 70%.1By prioritizing global data sharing over traditional academic silos, the PRECEDE Consortium aims to shift the diagnosis of pancreatic cancer toward earlier, resectable stages. The consortium was stablished as a response to the failure of previous individual-led strategies…

Read More